Pharnext (XPAR:ALPHA) Other Gross PPE : €0.00 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Pharnext Other Gross PPE?

Pharnext's Other Gross PPE for the quarter that ended in Dec. 2023 was €0.00 Mil.

Pharnext's quarterly Other Gross PPE increased from Dec. 2022 (€0.00 Mil) to Jun. 2023 (€0.73 Mil) but then declined from Jun. 2023 (€0.73 Mil) to Dec. 2023 (€0.00 Mil).

Pharnext's annual Other Gross PPE declined from Dec. 2021 (€0.29 Mil) to Dec. 2022 (€0.00 Mil) but then stayed the same from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€0.00 Mil).

Pharnext Other Gross PPE Historical Data

The historical data trend for Pharnext's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharnext Other Gross PPE Chart

Pharnext Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

0.59

0.01

0.29

Pharnext Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Gross PPE	Get a 7-Day Free Trial															0.29	0.06	-	0.73	-

Pharnext Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Pharnext (XPAR:ALPHA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharnext SA (XPAR:ALPHA) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

P0X0:Germany

Address

11-13 Rue Rene Jacques, Issy-Les-Moulineaux, FRA, 92130

Website

http://www.pharnext.com

Pharnext SA is a biopharmaceutical company developing treatments targeting neurodegenerative diseases. The company also develop a Pleotherapy technology platform. Its product in the pipeline includes SYNGILITY; PXT3003 and PXT864. The company's only segment being research and development on new pharmaceutical therapies based on Pleotherapy.

Pharnext (XPAR:ALPHA) Headlines

No Headlines